Cargando…
ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19
A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and become pandemic with thousands new deaths and infected cases globally. To address coronavirus disease (COVID-19), currently no effective drug or vaccine is available. This necessity motivated us to e...
Autores principales: | Fakhar, Zeynab, Khan, Shama, AlOmar, Suliman Y., Alkhuriji, Afrah, Ahmad, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794216/ https://www.ncbi.nlm.nih.gov/pubmed/33420186 http://dx.doi.org/10.1038/s41598-020-79918-3 |
Ejemplares similares
-
PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY
por: Mascarenhas, John, et al.
Publicado: (2023) -
CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
por: de Poel, Eyleen, et al.
Publicado: (2021) -
ABBV-744 induces autophagy in gastric cancer cells by regulating PI3K/AKT/mTOR/p70S6k and MAPK signaling pathways
por: Wang, Kun, et al.
Publicado: (2023) -
Tenofovir antiviral drug solubility enhancement with β-cyclodextrin inclusion complex and in silico study of potential inhibitor against SARS-CoV-2 main protease (M(pro))
por: Mohandoss, Sonaimuthu, et al.
Publicado: (2023) -
Relationship between KIR genotypes and HLA-ligands with SARS-CoV-2 infection in the Saudi population
por: Alomar, Suliman, et al.
Publicado: (2023)